BIODORON caps 150 mg 20 pce

7680380510165 CH-38051 N02CX 20.02.
BIODORON caps 150 mg 20 pce
BIODORON caps 150 mg 20 pce
BIODORON caps 150 mg 20 pce
1 / 3
google

Details

Product number
3805101
CPT
-
Packaging group
20
Unit
Kapsel(n)
Composition
ferrum-quarz (compositio e ferrum sulfuricum (praep. e siderit), quarz, mel, vinum) 100% 149.6 mg, color.: E 150a, excipiens pro capsula.

Articles (1)

Biodoron 150 mg, Hartkapseln
Kapseln
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/11/2023
Patient information leaflet
Français
16/11/2023
Patient information leaflet
Italien
16/11/2023
Professional SmPC
Allemand
25/09/2018
Professional SmPC
Français
25/09/2018

Detailed composition

Substance Quantity Type Category
(N/A)
149.6 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance FIMDK

Reimbursement information

Public price
CHF 26.55
Specialties list
Yes
Generic
No
SL addition date: 15/03/1998

Authorization holder

Weleda AG

4144 Arlesheim

Authorization information

Swissmedic authorization number
38051
Drug name
Biodoron 150 mg, Hartkapseln
Galenic form
KAHA
ATC Code
N02CX
Authorization status
Z
Dispensation category
B
First authorization
23/11/1982
Authorization expiration date
31/12/9999
IT number
20.02.
Domain
Human medicine
Field of application
Gemäss der anthroposophischen Menschen- und Naturerkenntnis zur Basis- (Intervall-) und Anfallsbehandlung von Migräne, vor allem der klassischen Migräne und bei vasomotorischen (migräneartigen) Kopfschmerzen

Packaging details

Description (FR)
BIODORON 150 mg, capsules 20 pce
Description (DE)
BIODORON 150 mg, Kapseln 20 Stk
Market launch
23/11/1982
Narcotic (BTM)
No

Other packaging sizes

BIODORON 150 mg, capsules 80 pce
80 KAP
GTIN: 7680380510240
View